SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (982)4/16/2001 9:15:17 PM
From: Spekulatius   of 3158
 
Roche news -
my take of the Roche news is that they are open to do an acquisition or a merger of equals, as well as further looking to boost their pipeline by licensing.
A merger of equals for Roche is unheard of, since its effectively controlled by the founders family.
However recently, a 1:100 stock split was approved which could very well predecent an conversion of nonvoting into voting shares, with the family effectively loosing control.

I do not know what this means for DNA though, right now Roche is even more dependent on DNA, because its pipeline is fairly weak near term.

Roche has been an a acquisition spree before; buying privately owned Boehringer a few years ago with cash. They have worked down the debt with free cash flow and the windfall from the DNA IPO deal and now they feel they have to do something again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News